enVVeno Medical Corporation(NVNO)

Description: enVVeno Medical is an Irvine, California based medical device company focused on the development of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company's lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study with data expected in late 2022.

---

Keywords: Ulcer Vascular Disease Circulatory System Cardiovascular System Angiology Veins Venous Ulcer Venous Insufficiency Chronic Venous Insufficiency Insufficiency Venous Disease Venous Hypertension

---

Home Page: www.envveno.com

NVNO Technical Analysis

70 Doppler
Irvine, CA 92618
United States
Phone: 949 261 2900

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)